XyloCor Therapeutics

King of Prussia, PA · Founded 2013 · Privately Held (backing)

Operator of a bio-pharmaceutical firm intended to develop gene therapy for people with advanced coronary artery disease. XyloCor Therapeutics is based in King of Prussia, PA and was founded in 2013. It was valued at $130 million at its later-stage round in Jan 2025, the last priced event on record. It has raised $122 million across 3 recorded rounds; the latest was a $4 million seed round in Jan 2021.

PMV mark · valuation
$130.0M
Oct 2026
Priced at
its later-stage round
Jan 2025
Total raised
$122.0M
Last round
Seed Round
Jan 2021
How much has XyloCor Therapeutics raised?
$122.0Macross 3 recorded rounds · Nov 2016 – Jan 2021

Most recently, XyloCor Therapeutics raised $4.0M in its Seed Round (Jan 2021).

Free account
More of XyloCor Therapeutics with a free account
  • ·Watch XyloCor Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

XyloCor Therapeutics round by round

3 rounds
Jan 2021Seed Round$4.0MSEC filing▮
5 investors participated
Oct 2018Early Stage VC$16.8MSEC filing▮
7 investors participated
Nov 2016Debt$250KSEC filing▮
1 investors participated

How much has XyloCor Therapeutics raised?

XyloCor Therapeutics has raised $122 million in total; 3 of its rounds are on record, from 2016 on. The largest on record was a $4 million seed round in Jan 2021.

XyloCor Therapeutics has filed 6 Form Ds with the SEC since 2016, most recently in Jan 2021 ($4 million sold to 5 investors).

XyloCor Therapeutics investors

8 investors are on record for XyloCor Therapeutics, including EQT Life Sciences, Cornell University, Fountain Healthcare Partners and Jeito. The seed round in Jan 2021 drew 5 investors.

For fundraisers
Raising for a company like XyloCor Therapeutics?

8 investors have backed XyloCor Therapeutics.

See all 8 investors →

Frequently asked about XyloCor Therapeutics

How much has XyloCor Therapeutics raised?
XyloCor Therapeutics has raised $122.0M in total across 3 recorded funding rounds.
When was XyloCor Therapeutics's last funding round?
XyloCor Therapeutics's most recent recorded round was Seed Round in Jan 2021, raising $4.0M.